nanotechnology

News

Nanotechnology makes big splash at nanotech commercialization conference

The American Tobacco Campus was the site of this year's Nanotech Commercialization Conference. Bay 7, a former tobacco warehouse, hosted most of the conference events. Stephen Waite, managing partner of SoundView Advisory, noted that 30 to 40 years ago, the warehouse was a busy place for rolling tobacco. "Now we're sitting here talking about rolling carbon nanotubes," he said.

Pharma

Why nanotech will eclipse biotech in size and scope: a CEO’s perspective

Nanotechnology products from Liquidia Technologies will first find their way to most Americans in medicine. The company’s proprietary method of making nanoparticles enables targeted drug delivery of medicines and vaccines. While Liquidia CEO Neal Fowler believes the technology will transform drug delivery around the world, he says his Research Triangle Park, North Carolina company sees […]

Pharma

Drug made from cobra venom among pharma startup’s targeted therapeutics

An early stage pharmaceutical company with newly licensed anticancer, anti-inflammatory and nanoparticle drug-delivery technologies is looking for its first round of funding. Pono Pharma, which was founded earlier this year with three technologies licensed from the University of Hawai’i, has already raised $1.5 million of a planned $4 million. The most novel of its drug […]

Pharma

CytImmune raising $1M for cancer treatment using gold nanoparticles

Nanomedicine company CytImmune disclosed in a recent U.S. Securities and Exchange Commission filing that it’s raising up to $1 million for its experimental cancer treatment, which uses nanoparticles of gold to deliver potent chemotherapy drugs to tumors. Now in the clinical stage, CytImmune has been working on its technology platform for more than 20 years. […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

News

Medicon Valley, meet Research Triangle Park, North Carolina

As Medicon Valley‘s visitors introduced themselves to their Research Triangle Park, North Carolina hosts, members of the Scandinavian delegation took care to note whether they speak Danish, Swedish or both. Medicon Valley is the life sciences cluster in Northern Europe that encompasses eastern Denmark and southwest Sweden. The cluster, spanning the Oresund Strait, includes 4 […]

Devices & Diagnostics

Ben Franklin to provide $3M for nanotechnology research

Ben Franklin Technology Development Authority has allocated $3.15 million in grants for colleges and universities along with their nonprofit partners to support nanotechnology research and development activities. The funding is designed to support early stage and established technology firms to encourage innovation and the creation of high-paying jobs throughout the state, according to a statement […]

Pharma

From farm to pharma: How nanotechnology bridges both worlds

Agriculture is North Carolina’s oldest and still its largest industry, and it could get even bigger with the help of one of the state’s newer  industries — biotechnology. The North Carolina Biotechnology Center  is spearheading an effort to grow the state’s agricultural industry from about $70 billion now to $100 billion by 2020 by linking […]

Devices & Diagnostics

Antibacterial technology from Novan lands $6M in new capital

Nanotechnology company Novan has raised $6 million in financing as the startup continues development of its nitric oxide technology into a bacteria-fighting tool. Securities filings show that Durham, North Carolina-based Novan’s latest round was a mix of equity and options. Investors include Neal Hunter, co-founder of Durham LED lighting technology company Cree (NASDAQ:CREE). Cree executive […]

News

ECU toxicologist gets $143K Biotech Center grant to study nanoparticle risks

Nanoparticle exposure research is getting a boost from a North Carolina Biotechnology Center grant. The Biotech Center has awarded East Carolina University toxicologist Jared Brown $143,308 to study the hazards from inhaling nanomaterials during their manufacture or use. Brown, an assistant professor in ECU’s Department of Pharmacology and Toxicology at the Brody School of Medicine, […]

Pharma

Emerging markets: A new driver for nanobiotechnology innovation

Nanotechnology might not be immediately evident in a small, isolated village in India, but Steve Walsh says such a place offers an important example of what drives nanobiomedical innovation. Residents there don’t have access to major testing labs, nor do they have the financial means for expensive care.  But they can now take advantage of […]

News

Nanotechnology in North Carolina: How N.C. became a nanobiotech hub

The nanotechnology industry mapped out across the United States is full of bubbles — the good kind. “Nano-metros” identified and mapped by the Project on Emerging Nanotechnologies, or PEN, depicts the nation’s nanotechnology hubs as bubbles. The larger the industry in a given region, the larger the bubble on the map. Silicon Valley, Boston and […]

News

Nanotech veteran Kundahl named to lead NC nanobiotech group COIN

The Center of Innovation for Nanobiotechnology, the nonprofit North Carolina nanobiotechnology group better known  as COIN, has named a nanotechnology industry veteran as its new executive director. Griffith Kundahl comes to Durham, North Carolina-based COIN from the University of Denver School of Engineering and Computer Science where he worked as director of global programs. His […]